Literature DB >> 10516663

Characterization of chemokine CCR3 agonist-mediated eosinophil recruitment in the Brown-Norway rat.

E M Kudlacz1, C A Whitney, C J Andresen, J P Umland, J B Cheng.   

Abstract

1. The ability of various C-C chemokines to elicit tissue eosinophil infiltration following intradermal injection or peripheral blood eosinophilia following intravenous injection were compared in the Brown-Norway rat. 2. Eotaxin (0.1 - 3 microg site-1) of human and murine origin produced equivalent, dose-dependent increases in eosinophil peroxidase activity in rat dermis 4 h post-injection. 3. Human eotaxin-2 was equipotent with human eotaxin in terms of dermal eosinophil recruitment. Other human CCR3 agonists, such as MCP-3, RANTES and MCP-4 failed to increase dermal eosinophil peroxidase activity at doses up to 1 microg site-1 whereas the latter did produce a small effect at 3 microg site-1. 4. Consistent with observations in vivo, human eotaxin displaced [125I]-eotaxin from rat spleen membranes more potently (IC50=2 nM) than did MCP-4 (IC50=500 nM). RANTES did not compete with the radiolabelled chemokine at concentrations up to 1 microM. 5. Human eotaxin (5 microg) administered intravenously increased circulating eosinophils approximately 3 fold whereas MCP-4 (5 microg i.v.) increased circulating monocytes approximately 3 fold without affecting eosinophil numbers. 6. Dexamethasone pretreatment inhibited eotaxin-induced dermal eosinophil influx only at a steroid dose (0.1 mg kg-1, s.c.) which significantly reduced circulating eosinophil numbers. The steroid also reduced eosinophilia in peripheral blood resulting from systemic eotaxin administration (5 microg, i.v.). 7. These data suggest differences in rat CCR3 relative to other species as surmised from a distinctive rank order of chemokine potency. In addition to its chemotactic effects eotaxin, but not MCP-4, promotes eosinophil recruitment into the circulation. One of the mechanisms by which glucocorticoids, such as dexamethasone, acutely inhibits eotaxin-induced dermal eosinophil influx is to diminish the circulating numbers of these cells available for tissue recruitment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516663      PMCID: PMC1571676          DOI: 10.1038/sj.bjp.0702835

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway.

Authors:  D H Broide; G J Gleich; A J Cuomo; D A Coburn; E C Federman; L B Schwartz; S I Wasserman
Journal:  J Allergy Clin Immunol       Date:  1991-10       Impact factor: 10.793

2.  Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors.

Authors:  M Strath; D J Warren; C J Sanderson
Journal:  J Immunol Methods       Date:  1985-11-07       Impact factor: 2.303

3.  Eosinophilic inflammation in asthma.

Authors:  J Bousquet; P Chanez; J Y Lacoste; G Barnéon; N Ghavanian; I Enander; P Venge; S Ahlstedt; J Simony-Lafontaine; P Godard
Journal:  N Engl J Med       Date:  1990-10-11       Impact factor: 91.245

4.  Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines.

Authors:  C Stellato; P Collins; P D Ponath; D Soler; W Newman; G La Rosa; H Li; J White; L M Schwiebert; C Bickel; M Liu; B S Bochner; T Williams; R P Schleimer
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

5.  Late airway responses to antigen challenge in sensitized inbred rats.

Authors:  D H Eidelman; S Bellofiore; J G Martin
Journal:  Am Rev Respir Dis       Date:  1988-05

6.  Cortisol-induced migration of eosinophil leukocytes to lymphoid organs.

Authors:  N Sabag; M A Castrillón; A Tchernitchin
Journal:  Experientia       Date:  1978-05-15

7.  Sputum ECP levels correlate with parameters of airflow obstruction.

Authors:  J C Virchow; U Hölscher; C Virchow
Journal:  Am Rev Respir Dis       Date:  1992-09

8.  Airway hyperresponsiveness is associated with inflammatory cell infiltration in allergic brown-Norway rats.

Authors:  W Elwood; P J Barnes; K F Chung
Journal:  Int Arch Allergy Immunol       Date:  1992       Impact factor: 2.749

9.  Recombinant human interleukin 5 is a selective eosinophil chemoattractant.

Authors:  J M Wang; A Rambaldi; A Biondi; Z G Chen; C J Sanderson; A Mantovani
Journal:  Eur J Immunol       Date:  1989-04       Impact factor: 5.532

10.  Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation.

Authors:  P J Jose; D A Griffiths-Johnson; P D Collins; D T Walsh; R Moqbel; N F Totty; O Truong; J J Hsuan; T J Williams
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.